This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, has completed its acquisition of Seisa Medical in a deal that significantly extends TekniPlex Healthcare’s medical technology solutions platform.
Based in El Paso, Texas, Seisa is a medical device manufacturer servicing every stage of the product life cycle including design and development, component manufacturing, and final assembly. It employs more than 2,000 people across four facilities in the U.S., Mexico and Slovakia.
“This acquisition elevates TekniPlex Healthcare into a full-fledged contract development manufacturing organization in the medical materials science space," said Chris Qualters, CEO for TekniPlex Healthcare. "Seisa's broad portfolio in the burgeoning interventional technologies niche—including its prowess with stent grafts, mitral heart valves, endovascular procedures and cardiovascular catheter delivery systems—complement our legacy capabilities exceptionally well. Combining Seisa's strengths with ours allows us to more comprehensively engage with customers to develop engineered materials, co-design components and assemblies, and provide sterile barrier products, among other categories."
"In TekniPlex Healthcare, we've found a partner that shares our longstanding commitment to delivering solutions that excel in challenging medical applications—ones that help save lives and improve patient outcomes," said Julio Chiu, Seisa founder and CEO. "Our customers can be reassured and encouraged that the combined strengths of Seisa and TekniPlex Healthcare will lead not only to sustained excellence, but also broadened capabilities and manufacturing platforms. This agreement instantly creates among the medical device industry's most robust, value-added CDMOs, to our customers' immediate benefit."
